Yongming Fu

522 total citations
17 papers, 380 citations indexed

About

Yongming Fu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Yongming Fu has authored 17 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Cancer Research. Recurrent topics in Yongming Fu's work include Cancer-related molecular mechanisms research (5 papers), Hepatitis B Virus Studies (3 papers) and Advanced Glycation End Products research (3 papers). Yongming Fu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Hepatitis B Virus Studies (3 papers) and Advanced Glycation End Products research (3 papers). Yongming Fu collaborates with scholars based in China and United States. Yongming Fu's co-authors include Daolin Tang, Yan Huang, Rongrong Zhou, Xuegong Fan, Xingwang Hu, Rui Kang, Yun Huang, Xuegong Fan, Lunquan Sun and Shaojun Liu and has published in prestigious journals such as Oncogene, World Journal of Gastroenterology and Cell Death and Disease.

In The Last Decade

Yongming Fu

16 papers receiving 375 citations

Peers

Yongming Fu
Comparison fields: 5 of 58
  • Molecular Biology 222
  • Cancer Research 186
  • Epidemiology 94
  • Immunology 58
  • Cell Biology 37
Replace Lei Lyu with:
Lei Lyu China
Zvi Shalev Israel
Xuemin Chen China
Mengdie Fang China
Zhen Sun China
Cody M. Spencer United States
Sainitin Donakonda Germany
Young‐Suk Yoo South Korea
Ruo Feng China
Mojtaba Darbouy Iran
Lei Lyu China View profile →
Citations per field, relative to Yongming Fu
Yongming Fu · 1×
Citations per year, relative to Yongming Fu
Yongming Fu · 1×

Countries citing papers authored by Yongming Fu

Since Specialization
Citations

This map shows the geographic impact of Yongming Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongming Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongming Fu more than expected).

Fields of papers citing papers by Yongming Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongming Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongming Fu. The network helps show where Yongming Fu may publish in the future.

Co-authorship network of co-authors of Yongming Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongming Fu. A scholar is included among the top collaborators of Yongming Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongming Fu. Yongming Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Work Indexed citations
1 0
2 15
3
Psoralidin inhibits the proliferation of human liver cancer cells by triggering cell cycle arrest, apoptosis and autophagy and inhibits tumor growth in vivo.
8
4 13
5 21
6 35
7 16
8 21
9 30
10 12
11 12
12 14
13 128
14 38
15 4
16 6
17 7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026